Fig. 5
The changes with time in the time required to ascend and descend a flight of stairs at weeks 0, 4, and 12 in the Curamin, CuraMed and placebo treatment groups. Within-group improvements (*p < 0.05, **p < 0.01, ***p < 0.001) in physical performance tests at the end of the study (visit 3) compared to baseline (week 0)